Certara Inc (CERT)

概要ニュース株価時系列オプションチェーン Financials ディスカッション予測

Relative Volume:

ネットキャッシュフロー:

Certara Inc Stock (CERT) Company Profile

Healthcare (1167)

(415) 237-8272

4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR

CERT's Discussions on Twitter

CERT を他の銘柄と比較する

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
CERT Certara Inc	9.86	1.61B	363.55M	-78.68M	50.74M	-0.50
VEEV Veeva Systems Inc	234.93	38.81B	2.75B	714.14M	1.09B	4.33
SOLV Solventum Corp	74.96	12.84B	8.26B	66.00M	1.17B	0.3682
DOCS Doximity Inc	58.63	11.36B	516.85M	174.11M	217.38M	0.87
TEM Tempus Ai Inc	48.16	10.16B	640.44M	-743.28M	-206.93M	-11.29
HQY Healthequity Inc	86.67	7.53B	1.15B	96.70M	-161.99M	1.09

Certara Inc Stock (CERT) Upgrades & Downgrades

日付	アクション	アナリスト	評価の変更
2025-02-27	開始されました	TD Cowen	Buy
2024-09-27	アップグレード	UBS	Neutral → Buy
2024-04-10	アップグレード	KeyBanc Capital Markets	Sector Weight → Overweight
2024-04-04	開始されました	JMP Securities	Mkt Perform
2024-02-26	開始されました	Leerink Partners	Market Perform
2023-12-07	開始されました	UBS	Neutral
2023-12-05	開始されました	KeyBanc Capital Markets	Sector Weight
2023-08-22	ダウングレード	Jefferies	Buy → Hold
2023-08-10	ダウングレード	William Blair	Outperform → Mkt Perform
2023-04-12	開始されました	Stephens	Overweight
2023-04-03	ダウングレード	Barclays	Overweight → Equal Weight
2022-12-14	ダウングレード	Robert W. Baird	Outperform → Neutral
2022-09-08	開始されました	Berenberg	Buy
2022-08-25	開始されました	Credit Suisse	Outperform
2022-07-01	開始されました	Piper Sandler	Overweight
2022-01-11	アップグレード	Jefferies	Hold → Buy
2021-08-05	再開されました	Credit Suisse	Neutral
2021-07-23	開始されました	Robert W. Baird	Outperform
2021-03-03	開始されました	Barclays	Overweight
2021-01-06	開始されました	Morgan Stanley	Equal-Weight
2021-01-05	開始されました	BofA Securities	Buy
2021-01-05	開始されました	Credit Suisse	Neutral
2021-01-05	開始されました	Jefferies	Hold
2021-01-05	開始されました	William Blair	Outperform

Certara Inc (CERT) 最新ニュース

Certara Inc (CERT) 財務データ

Certara Inc (CERT)

Certara Inc Stock (CERT) Company Profile

CERT を他の銘柄と比較する

Certara Inc Stock (CERT) Upgrades & Downgrades

Certara Inc (CERT) 最新ニュース

Raymond James Financial Inc. Takes Position in Certara, Inc. (NASDAQ:CERT) - Defense World

Certara, Inc. (NASDAQ:CERT) Receives $15.83 Consensus Price Target from Brokerages - Defense World

Certara, Inc. (NASDAQ:CERT) Shares Purchased by HighTower Advisors LLC - Defense World

Avantax Advisory Services Inc. Sells 17,660 Shares of Certara, Inc. (NASDAQ:CERT) - Defense World

Charles Schwab Investment Management Inc. Grows Holdings in Certara, Inc. (NASDAQ:CERT) - Defense World

PNC Financial Services Group Inc. Raises Stock Position in Certara, Inc. (NASDAQ:CERT) - Defense World

Amundi Raises Holdings in Certara, Inc. (NASDAQ:CERT) - Defense World

Atria Investments Inc Reduces Position in Certara, Inc. (NASDAQ:CERT) - Defense World

US Bancorp DE Has $101,000 Stock Position in Certara, Inc. (NASDAQ:CERT) - Defense World

(CERT) Technical Data - Stock Traders Daily

Proficio Capital Partners LLC Takes Position in Certara, Inc. (NASDAQ:CERT) - Defense World

Certara’s SWOT analysis: ai-driven biosimulation firm faces growth challenges By Investing.com - Investing.com South Africa

Certara’s SWOT analysis: ai-driven biosimulation firm faces growth challenges - Investing.com Australia

Certara at Barclays Healthcare: Strategic Shift Toward Biosimulation - Investing.com India

Certara at Barclays Healthcare: Strategic Shift Toward Biosimulation By Investing.com - Investing.com South Africa

Certara Inc (NASDAQ: CERT) – Analysts’ Revisions Point To Positive Sentiment - Stocks Register

Bank of New York Mellon Corp Purchases 1,253,385 Shares of Certara, Inc. (NASDAQ:CERT) - Defense World

23,568 Shares in Certara, Inc. (NASDAQ:CERT) Acquired by Private Advisor Group LLC - Defense World

Certara, Inc. (CERT): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts - Insider Monkey

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions - citybiz

Certara announces leadership change in drug development By Investing.com - Investing.com South Africa

Certara announces leadership change in drug development - Investing.com India

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions -March 05, 2025 at 05:07 pm EST - Marketscreener.com

Certara Announces Leadership Change with Dr. Smith’s Departure - TipRanks

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions -March 05, 2025 at 04:16 pm EST - Marketscreener.com

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions -March 05, 2025 at 04:15 pm EST - Marketscreener.com

Can This Former IQVIA Executive Transform Certara's Drug Development Approach? - StockTitan

Principal Financial Group Inc. Has $5.66 Million Stock Position in Certara, Inc. (NASDAQ:CERT) - Defense World

Objective long/short (CERT) Report - Stock Traders Daily

Q2 Earnings Estimate for Certara Issued By William Blair - Defense World

Certara (NASDAQ:CERT) Price Target Raised to $13.00 - Defense World

Q1 Earnings Estimate for Certara Issued By Leerink Partnrs - Defense World

Rhumbline Advisers Has $2.96 Million Stock Holdings in Certara, Inc. (NASDAQ:CERT) - Defense World

Brokerages Set Certara, Inc. (NASDAQ:CERT) Price Target at $15.42 - Defense World

KeyBanc maintains Overweight rating on Certara shares with $15 target - Investing.com India

KeyBanc maintains Overweight rating on Certara shares with $15 target By Investing.com - Investing.com South Africa

Certara’s Earnings Call Highlights Growth Amid Challenges - TipRanks

Certara, Inc. (NASDAQ:CERT) Q4 2024 Earnings Call Transcript - MSN

Certara, Inc. (CERT) Surpasses Q4 Earnings and Revenue Estimates - MSN

TD Cowen Initiates Coverage on Certara With Buy Rating, $16 Price Target -February 27, 2025 at 08:30 am EST - Marketscreener.com

TD Cowen sets Certara stock Buy rating, $16 target By Investing.com - Investing.com Canada

TD Cowen sets Certara stock Buy rating, $16 target - Investing.com India

Certara Inc (CERT) 財務データ

収益

当期純利益

現金流量

EPS

CERTに似た銘柄